(Q24245237)

English

Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease

scientific article

In more languages

Statements

scholarly article

0 references

0 references

1 reference

Europe PubMed Central

Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease (English)

0 references

1 reference

based on heuristic

inferred from title

4

object named as

Joseph Lau

0 references

author name string

Bart van Pinxteren

1

0 references

Kirsten E Sigterman

2

0 references

Peter Bonis

3

0 references

Mattijs E Numans

5

0 references

publication date

19 July 2006

0 references

Cochrane Database of Systematic Reviews

0 references

Symptomatic gastro-oesophageal reflux disease: double blind controlled study of intermittent treatment with omeprazole or ranitidine. The European Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002095.PUB3

21 January 2018

Heartburn treatment in primary care: randomised, double blind study for 8 weeks

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002095.PUB3

21 January 2018

Double blind cross-over placebo controlled study of omeprazole in the treatment of patients with reflux symptoms and physiological levels of acid reflux--the "sensitive oesophagus"

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002095.PUB3

21 January 2018

Heartburn requiring frequent antacid use may indicate significant illness

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002095.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Lansoprazole compared with ranitidine for the treatment of nonerosive gastroesophageal reflux disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002095.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of omeprazole for the treatment of symptomatic acid reflux disease without esophagitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002095.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Ranitidine therapy for gastroesophageal reflux disease. Results of a large double-blind trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002095.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Empiric therapy for gastroesophageal reflux disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002095.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Symptomatic gastroesophageal reflux: incidence and precipitating factors

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002095.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Controlled trial of cimetidine in reflux esophagitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002095.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Double-blind comparison of cisapride and cimetidine in treatment of reflux esophagitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002095.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized, double-blind, placebo-controlled clinical study of the histamine H2-receptor antagonist famotidine in Japanese patients with nonerosive reflux disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002095.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of omeprazole in Japanese patients with nonerosive reflux disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002095.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of rabeprazole in the treatment of symptomatic gastroesophageal reflux disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002095.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Symptoms in gastro-oesophageal reflux disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002095.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Rabeprazole-based therapy in the management of symptomatic gastroesophageal reflux disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002095.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002095.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of cimetidine in symptomatic gastro-oesophageal reflux

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002095.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Reductions in symptom distress reported by patients with moderately severe, nonerosive gastroesophageal reflux disease treated with rabeprazole

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002095.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Reflux symptom relief with omeprazole in patients without unequivocal oesophagitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002095.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Treating the symptoms of gastro-oesophageal reflux disease: a double-blind comparison of omeprazole and cisapride.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002095.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Omeprazole is more effective than cimetidine for the relief of all grades of gastro-oesophageal reflux disease-associated heartburn, irrespective of the presence or absence of endoscopic oesophagitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002095.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Lansoprazole in the treatment of heartburn in patients without erosive oesophagitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002095.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of motilin agonist ABT-229 on gastro-oesophageal reflux, oesophageal motility and lower oesophageal sphincter characteristics in GERD patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002095.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Esomeprazole resolves chronic heartburn in patients without erosive oesophagitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002095.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: a meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002095.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

A Controlled Trial of Metoclopramide in Symptomatic Gastroesophageal Reflux

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002095.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Symptom-relieving Effect of Esomeprazole 40 mg Daily in Patients with Heartburn

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002095.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

One-week Esomeprazole Treatment: an Effective Confirmatory Test in Patients with Suspected Gastroesophageal Reflux Disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002095.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

One-week omeprazole treatment in the diagnosis of gastro-oesophageal reflux disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002095.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Gastro-oesophageal reflux symptoms--clinical findings and effect of ranitidine treatment

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002095.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Cimetidine, metoclopramide, or placebo in the treatment of symptomatic gastroesophageal reflux

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002095.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Pantoprazole rapidly improves health-related quality of life in patients with heartburn: a prospective, randomized, double blind comparative study with nizatidine

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002095.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Cimetidine suspension in patients with stage 0 gastro-oesophageal reflux disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002095.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Cimetidine improves GERD symptoms in patients selected by a validated GERD questionnaire

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002095.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Classification of dyspepsia and response to treatment with proton-pump inhibitors.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002095.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Heartburn-dominant, uninvestigated dyspepsia: a comparison of 'PPI-start' and 'H2-RA-start' management strategies in primary care--the CADET-HR Study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002095.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Famotidine vs. omeprazole: a prospective randomized multicentre trial to determine efficacy in non-erosive gastro-oesophageal reflux disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002095.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

One-week acid suppression trial in uninvestigated dyspepsia patients with epigastric pain or burning to predict response to 8 weeks' treatment with esomeprazole: a randomized, placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002095.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized-controlled trial of esomeprazole in functional dyspepsia patients with epigastric pain or burning: does a 1-week trial of acid suppression predict symptom response?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002095.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term management of patients with symptoms of gastro-oesophageal reflux disease -- a Norwegian randomised prospective study comparing the effects of esomeprazole and ranitidine treatment strategies on health-related quality of life in a general

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002095.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Esophageal hypersensitivity may be a major cause of heartburn

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002095.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Quality of life in patients with heartburn but without esophagitis: effects of treatment with omeprazole.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002095.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Rabeprazole in nonerosive gastroesophageal reflux disease: a randomized placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002095.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Empiric treatment with high and standard dose of omeprazole in general practice: two-week randomized placebo-controlled trial and 12-month follow-up of health-care consumption

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002095.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized trial comparing omeprazole, ranitidine, cisapride, or placebo in helicobacter pylori negative, primary care patients with dyspepsia: the CADET-HN Study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002095.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002095.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002095.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Heartburn--the acid test

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002095.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of famotidine on oesophageal sensitivity in gastro-oesophageal reflux disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002095.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Reflux related symptoms in patients with normal oesophageal exposure to acid

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002095.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Gastro-oesophageal reflux disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002095.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of pantoprazole versus ranitidine in the treatment of patients with symptomatic gastroesophageal reflux disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002095.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Cimetidine in gastro-oesophageal reflux

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002095.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Double-blind crossover study of ranitidine and placebo in gastro-oesophageal reflux disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002095.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Oesophagitis, signs of reflux, and gastric acid secretion in patients with symptoms of gastro-oesophageal reflux disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002095.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Symptoms and endoscopic findings in the diagnosis of gastroesophageal reflux disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002095.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Relevance of norm values as part of the documentation of quality of life instruments for use in upper gastrointestinal disease.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002095.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Omeprazole 10 milligrams once daily, omeprazole 20 milligrams once daily, or ranitidine 150 milligrams twice daily, evaluated as initial therapy for the relief of symptoms of gastro-oesophageal reflux disease in general practice

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002095.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Heartburn without oesophagitis: efficacy of omeprazole therapy and features determining therapeutic response

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002095.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevalence of symptoms suggestive of gastro-oesophageal reflux disease in an adult population.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002095.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised controlled trial of pantoprazole versus ranitidine for the treatment of uninvestigated heartburn in primary care.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002095.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/14651858.CD002095.PUB3

0 references

PubMed publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q24245237&oldid=1514077728"